These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8157888)

  • 21. Tamoxifen and endometrial pathologies: a prospective study.
    Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H
    Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
    Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
    Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian hyperstimulation syndrome associated with clomiphene citrate.
    Mitchell SY; Fletcher HM; Williams E
    West Indian Med J; 2001 Sep; 50(3):227-9. PubMed ID: 11769032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ovulation induction therapy and systemic lupus erythematosus].
    Lê Thi Huong D; Wechsler B; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):45-50. PubMed ID: 12746658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protecting the endometrium. Opposing the hyperplasia/malignancy potential of ERT.
    Gibbons WE; Thorneycroft IH
    J Reprod Med; 1999 Feb; 44(2 Suppl):203-8. PubMed ID: 11392033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infertility as a cancer risk factor - a review.
    Cetin I; Cozzi V; Antonazzo P
    Placenta; 2008 Oct; 29 Suppl B():169-77. PubMed ID: 18790330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin.
    Vlahos NF; Coker L; Lawler C; Zhao Y; Bankowski B; Wallach EE
    Fertil Steril; 2005 May; 83(5):1510-6. PubMed ID: 15866592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of testosterone on the development of endometrial tumors in female rats.
    Terada S; Suzuki N; Uchide K; Akasofu K; Nishida E
    Gynecol Obstet Invest; 1993; 36(1):29-33. PubMed ID: 8349175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ovulation induction and the risk of ovarian tumors].
    Franco C; Coppola S; Prosperi Porta R; Patella A
    Minerva Ginecol; 2000 Apr; 52(4):103-9. PubMed ID: 10900940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent molar pregnancies associated with clomiphene citrate and human gonadotropins.
    Mor-Joseph S; Anteby SO; Granat M; Brzezinsky A; Evron S
    Am J Obstet Gynecol; 1985 Apr; 151(8):1085-6. PubMed ID: 3920913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women.
    Buccoliero AM; Gheri CF; Castiglione F; Garbini F; Barbetti A; Fambrini M; Bargelli G; Pappalardo S; Taddei A; Boddi V; Scarselli GF; Marchionni M; Taddei GL
    Cytopathology; 2007 Aug; 18(4):241-9. PubMed ID: 17559564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review.
    Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R
    Acta Obstet Gynecol Scand; 2008; 87(11):1101-13. PubMed ID: 18607816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
    Bangsbøll S
    Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian stimulation and granulosa-cell tumour.
    Evers JL
    Lancet; 1993 May; 341(8856):1345; author reply 1345-6. PubMed ID: 8098470
    [No Abstract]   [Full Text] [Related]  

  • 40. Ischemic stroke due to induction of ovulation with clomiphene citrate and menotropins without evidence of ovarian hyperstimulation syndrome.
    Inbar OJ; Levran D; Mashiach S; Dor J
    Fertil Steril; 1994 Nov; 62(5):1075-6. PubMed ID: 7926122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.